Profound Medical to Release Second Quarter 2026 Financial Results on August 6th
Profound Medical Corp., a developer of innovative MRI-guided medical devices, will release its Q2 2026 financial results on August 6, 2026, and hosts a conference call to discuss business developments. The company specializes in non-invasive, MRI-guided therapies primarily for prostate cancer and other conditions, with its FDA-cleared TULSA-PRO pla…